ArticleOncotarget2018

Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.

Kei Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.